Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefitinib added to postoperative chemoradiation for head and neck squamous cell carcinoma
ACTRN12605000510640Phase 2Recruiting
- Sponsor
- Peter MacCallum Cancer Centre
- Start
- Jul 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of gefitinib, sponsored by Peter MacCallum Cancer Centre. Started Jul 2004; status: recruiting.
02
Drugs
Beyond the preview
Go deeper on ACTRN12605000510640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12605000510640.